ClinicalTrials.gov
public full text
Public Domain
Simultaneous Integrated Boost With Volumetric Arc Radiotherapy in Patients With Breast Cancer
The study will include 27 patients to study the dosimetric data and acute toxicity. Patients will be treated by SIB intensity modulated radiotherapy (IMRT) boost to the cavity.The dose to be delivered will be a hypo fractionated regimen of 34Gy/10#/2weeks to the whole breast and 40Gy/10#/2weeks to the tumour bed. The dose to the target and to the OAR will be observed. The acute toxicity and cosmesis will be assessed.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- AI for Head Neck Cancer Treated With Adaptive RadioTherapy (RadiomicART)#1059442
- IMRT Followed by CyberKnife Boost Focused on the Gross Residual Pelvic Tumor Volume#1162714
- Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM)#1171369
- Exclusive Intraoperative Radiation Therapy for Breast Cancer#915040
- Ultra-hypofractionated Radiotherapy in Breast Cancer Patients#834713
Record · ID 1394617
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive